UBS Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-120,549
| Closed | -$1.16M | – | 9550 |
|
|
2024
Q4 | $1.16M | Buy |
120,549
+50,832
| +73% | +$488K | ﹤0.01% | 4116 |
|
|
2024
Q3 | $199K | Buy |
69,717
+16,094
| +30% | +$46K | ﹤0.01% | 4702 |
|
|
2024
Q2 | $157K | Sell |
53,623
-21,723
| -29% | -$63.4K | ﹤0.01% | 4715 |
|
|
2024
Q1 | $240K | Buy |
75,346
+8,394
| +13% | +$26.8K | ﹤0.01% | 4577 |
|
|
2023
Q4 | $225K | Buy |
66,952
+31,144
| +87% | +$105K | ﹤0.01% | 4539 |
|
|
2023
Q3 | $85.2K | Sell |
35,808
-3,408
| -9% | -$8.11K | ﹤0.01% | 4820 |
|
|
2023
Q2 | $69K | Buy |
39,216
+27,203
| +226% | +$47.9K | ﹤0.01% | 5226 |
|
|
2023
Q1 | $37K | Buy |
12,013
+7,840
| +188% | +$24.1K | ﹤0.01% | 5561 |
|
|
2022
Q4 | $22.1K | Buy |
+4,173
| New | +$22.1K | ﹤0.01% | 6374 |
|
|
2022
Q1 | – | Sell |
-9,795
| Closed | -$67K | – | 9730 |
|
|
2021
Q4 | $67K | Buy |
+9,795
| New | +$67K | ﹤0.01% | 5579 |
|
|
2021
Q3 | – | Sell |
-2,000
| Closed | -$20K | – | 8895 |
|
|
2021
Q2 | $20K | Sell |
2,000
-115,782
| -98% | -$1.16M | ﹤0.01% | 6256 |
|
|
2021
Q1 | $1.13M | Buy |
117,782
+9,706
| +9% | +$92.7K | ﹤0.01% | 3257 |
|
|
2020
Q4 | $1.19M | Buy |
108,076
+1,991
| +2% | +$21.8K | ﹤0.01% | 3028 |
|
|
2020
Q3 | $941K | Buy |
+106,085
| New | +$941K | ﹤0.01% | 2963 |
|